Physician

Joshua Marks Greenhoe, MD

According to 2025 Medicare claims, Joshua Greenhoe, MD (NPI: 1780640680) practices internal medicine in the Charlottesville, VA market, with the plurality of this provider's patient population coming from Charlottesville City, VA. This provider's primary affiliated billing organization is MARTHA JEFFERSON MEDICAL GROUP LLC (NPI: 1275720559; TIN: 261126956) and primary practice location at 22911-4628. Greenhoe is affiliated with the Sentara Accountable Care Organization, LLC (ACO ID: A4868), participating under the MSSP model.

Greenhoe's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 770 traditional Medicare patients, billed 5,124 HCPCS/CPT codes, and received $294,315 in Medicare payments. The top billing code was G0439 (Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit). Part D data shows 13,199 prescription claims across 1,046 beneficiaries totaling $1,021,548 in drug costs, led by Eliquis (Apixaban). DME data shows 163 claims. No Open Payments records. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved sharply higher in recent years, from $141,950 to $294,315. Similarly, Part D prescription costs have moved sharply higher in recent years, from $365,920 to $1,021,548. In contrast, DME billing represents a smaller volume and moved from a lower plateau to a higher plateau, from $6,241 to $17,327.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	620	4,725	$141,950
2016	586	4,063	$133,807
2017	599	4,770	$145,377
2018	596	4,633	$149,309
2019	548	2,750	$109,635
2020	579	2,800	$131,994
2021	800	3,779	$207,619
2022	765	4,060	$229,621
2023	806	3,760	$274,908
2024	770	5,124	$294,315

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	440	5,881	$365,920
2016	412	5,634	$349,239
2017	459	5,746	$319,107
2018	465	5,699	$278,522
2019	487	4,664	$282,904
2020	523	5,023	$306,712
2021	651	6,950	$440,288
2022	839	8,602	$582,869
2023	1,009	11,617	$906,624
2024	1,046	13,199	$1,021,548

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	67	234	$6,286
2016	43	263	$5,049
2017	26	155	$2,024
2018	22	92	$836
2019	36	122	$1,022
2020	17	114	$2,138
2021	18	129	$5,761
2022	17	153	$8,460
2023	25	160	$10,172
2024	24	163	$8,975

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
G0439	Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit	666	666	$133
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	738	1,312	$84
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	190	264	$61
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's	407	645	$12
36415	Insertion of needle into vein for collection of blood sample	635	1,007	$9

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Eliquis	Apixaban	168	11,137	$211,428
Jardiance	Empagliflozin	76	5,074	$95,686
Ozempic	Semaglutide	78	3,140	$85,673
Trulicity	Dulaglutide	38	1,942	$64,115
Farxiga	Dapagliflozin Propanediol	52	2,653	$48,809

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
A4239	Supply allowance for non-adjunctive, non-implanted continuous glucose monitor (cgm), includes all supplies and accessories, 1 month supply = 1 unit of service	N	N/R	15	$4,308
E1390	Oxygen concentrator, single delivery port, capable of delivering 85 percent or greater oxygen concentration at the prescribed flow rate	Y	N/R	34	$3,091
A4253	Blood glucose test or reagent strips for home blood glucose monitor, per 50 strips	N	24	60	$903
E0431	Portable gaseous oxygen system, rental; includes portable container, regulator, flowmeter, humidifier, cannula or mask, and tubing	Y	N/R	35	$654
A4259	Lancets, per box of 100	N	N/R	19	$19

Open Payments Summary

No connected Open Payments records were found for this physician in General Payments, Research Payments, or Ownership / Investment Interests.

Explore More Providers

FAQ

What Medicare data is available for Joshua Marks Greenhoe, MD?

Tedicare shows public-source Medicare data for Joshua Marks Greenhoe, MD (NPI 1780640680), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Joshua Marks Greenhoe, MD have ACO affiliation data?

Joshua Marks Greenhoe, MD is shown with ACO affiliation data for Sentara Accountable Care Organization, LLC (MSSP, ACO ID A4868).

What billing organization is linked to Joshua Marks Greenhoe, MD?

Joshua Marks Greenhoe, MD is linked to MARTHA JEFFERSON MEDICAL GROUP LLC (billing NPI 1275720559) in the available physician profile data.

Does Joshua Marks Greenhoe, MD have Open Payments data?

No connected Open Payments records are shown for this physician in the available General Payments, Research Payments, or Ownership / Investment Interests data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.